Caplin Point Laboratories Limited has disclosed comprehensive voting results and scrutinizer report for the postal ballot concluded on January 31, 2026, revealing overwhelming shareholder support for the appointment of four new directors. The pharmaceutical company informed stock exchanges about the detailed voting outcomes under Regulation 44 of SEBI Listing Regulations.

Postal Ballot Process and Timeline

The postal ballot process was conducted entirely through remote e-voting, with the voting period commencing on January 2, 2026 at 9:00 AM and concluding on January 31, 2026 at 5:00 PM. The company dispatched the postal ballot notice dated December 29, 2025 via email to shareholders on December 31, 2025, with the cut-off date for voting eligibility set as December 26, 2025.

Voting Results Summary

All four resolutions received substantial shareholder approval, with voting participation reaching 78.35% of outstanding shares. The scrutinizer M. Alagar of Alagar & Associates LLP confirmed that all resolutions passed with requisite majority.

Detailed Voting Breakdown

The voting results demonstrated strong support across all shareholder categories. Promoter and Promoter Group, holding 53,642,353 shares, voted unanimously in favor of all resolutions with 100% participation. Public institutional investors, with 6,684,623 shares, showed 87.35% participation, while public non-institutional shareholders had 0.48% participation from their 15,684,720 shares.

New Board Appointments

The approved appointments include strategic leadership additions and enhanced independent oversight:

Professional Credentials

Mrs. Susan Mathew brings distinguished administrative expertise as a retired Indian Administrative Service officer with 36 years of government service. Her career included senior roles as Collector of Madras, Secretary to Government Energy Department, Chairman of Tamil Nadu Electricity Board, and Additional Chief Secretary. She holds academic credentials from Women's Christian College Chennai and was awarded the Lester Pearson Fellowship for studies at Carleton University and University of Ottawa.

Regulatory Compliance and Documentation

The company ensured full regulatory compliance with advertisements published in Financial Express (English) and Maalai Malar (Tamil) on January 1, 2026. The scrutinizer confirmed that all new directors meet regulatory requirements and are not debarred by SEBI or other authorities. Electronic voting data and records will be maintained in safe custody until the Chairman approves and signs the postal ballot minutes.

Caplin point laboratories Limited has announced a post-results conference call with analysts, fund houses, and investors to discuss its financial performance for the quarter ended December 31, 2025. The earnings call is scheduled for Thursday, February 05, 2026, at 16:00 hrs IST.

Regulatory Compliance and Announcement Details

The company made this announcement on January 29, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was formally communicated to both BSE Limited and the National Stock Exchange of India Ltd through their respective corporate relationship departments.

Management Representation

The Q3FY26 earnings conference call will feature key members of Caplin Point Laboratories' senior management team:

Conference Call Access Information

Participants can join the earnings call through multiple access methods. The conference provides universal access numbers including +91 22 6280 1116 and +91 22 7115 8017 for domestic participants.

International Participation Options

International participants can access the call through dedicated toll-free numbers:

Coordination and Contact Details

The conference call is being coordinated by Dolat Capital Market Pvt. Ltd. Participants requiring additional information can contact Kapil Yadav, Director Equity Sales & Corporate Access, or Candice Pareira, AVP Research, at their respective contact numbers and email addresses.

Important Notes

The company has indicated that the schedule of the meeting is subject to change due to exigencies on the part of analysts or the company. The announcement was digitally signed by Venkatram G, General Counsel & Company Secretary, with membership number A23989, ensuring proper authorization and compliance with regulatory requirements.